Skip to main content

Table 4 Odds ratios and 95% confidence intervals (CI) for genotype as predictor of sustained virological response after treatment with peginterferon and ribavirin in 432 chronically HCV infected patients, divided by age

From: Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: A Danish nationwide cohort study

  

Age ≤ 45 years

Age > 45 years

  

Odds ratio (95% CI)*

Odds ratio (95% CI)*

Genotype

1

1

1

 

2/3

1.42 (0.62-3.24)

3.00 (1.65-5.47)

  1. *adjusted for gender, nationality, route of infection, HCV-RNA, ALT, treating department (gastroenterology/hepatology vs. infectious diseases), treatment completion as scheduled, ended before scheduled or dose reduction